Beaver Run Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2001
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Human Genetics and Genomics (E2)
Organizer(s) Aravinda Chakravarti, Lap-Chee Tsui and Stephen Fodor
March 31—April 6, 2001
Beaver Run Resort • Breckenridge, Colorado USA
Abstract Deadline: Nov 30, 2000
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Jan 30, 2001
Sponsored by SmithKline Beecham Pharmaceuticals
Summary of Meeting:
Tremendous strides have been made in the structural analysis of large genomes, such that, the majority of the human genomic sequence will be completed by the year 2000. In parallel, advances in genetics have elucidated the molecular features of several mendelian traits and diseases, provided insight into disease mechanisms, and clarified how evolution has shaped the structure and function of specific genes. The greatest challenge now is to use the genomic sequence to gain an understanding of how the features of complex genetic systems in humans are encoded within the genome. More generally, how will we understand function from sequence? The purpose of the proposed meeting is to bring together key investigators in genomic technologies and genetics, from both the academic and industrial sectors, to identify the major questions and formulate new approaches for elucidating human genetics in the future.
View Scholarships/Awards
Tremendous strides have been made in the structural analysis of large genomes, such that, the majority of the human genomic sequence will be completed by the year 2000. In parallel, advances in genetics have elucidated the molecular features of several mendelian traits and diseases, provided insight into disease mechanisms, and clarified how evolution has shaped the structure and function of specific genes. The greatest challenge now is to use the genomic sequence to gain an understanding of how the features of complex genetic systems in humans are encoded within the genome. More generally, how will we understand function from sequence? The purpose of the proposed meeting is to bring together key investigators in genomic technologies and genetics, from both the academic and industrial sectors, to identify the major questions and formulate new approaches for elucidating human genetics in the future.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
SATURDAY, MARCH 31
SUNDAY, APRIL 1
MONDAY, APRIL 2
TUESDAY, APRIL 3
WEDNESDAY, APRIL 4
THURSDAY, APRIL 5
FRIDAY, APRIL 6
Conference Program Print | View meeting in 12 hr (am/pm) time
SATURDAY, MARCH 31
19:30—20:30
Keynote Address
Meeting has ended...abstracts no longer viewable online.
*
Aravinda Chakravarti,
Johns Hopkins University School of Medicine, USA
Harold E. Varmus,
Weill Cornell Medical College, USA
08:00—10:00
Structural and Comparative Genomics
Meeting has ended...abstracts no longer viewable online.
*
Lap-Chee Tsui,
University of Hong Kong, China
Francis S. Collins,
Director, National Institutes of Health, USA
Contemplating the End of the Beginning
Contemplating the End of the Beginning
David R. Cox,
Perlegen Sciences, Inc., USA
Evolutionary Footprints in the Human Genome
Evolutionary Footprints in the Human Genome
10:00—12:00
Genome-Scale Nucleic Acid Analysis
Meeting has ended...abstracts no longer viewable online.
*
Stephen P.A. Fodor,
Cellular Research, Inc., USA
David J. Lockhart,
Amicus Therapeutics, Inc., USA
Genes, Drugs, Brains and Bugs
Genes, Drugs, Brains and Bugs
Richard A. Mathies,
University of California, Berkeley, USA
Microfabricated Capillary Array Electrophoretic DNA Analysis Systems
Microfabricated Capillary Array Electrophoretic DNA Analysis Systems
16:00—18:00
Genome Function and Regulation
Meeting has ended...abstracts no longer viewable online.
Ira Herskowitz,
University of California, San Francisco, USA
Pathways and Networks in Yeast
Pathways and Networks in Yeast
Eric H. Davidson,
California Institute of Technology, USA
Genomic Regulatory Systems for Development
Genomic Regulatory Systems for Development
20:00—22:00
Poster Sessions 1 & 2: Structural and Comparative Genomics/Genome-Scale Nucleic Acid Analysis/Genome-Scale Protein Analysis/Genome Function and Regulation/Genomic Mechanisms/Evolution and Development
08:00—10:00
Genomic Features and Mechanisms
Meeting has ended...abstracts no longer viewable online.
*
Francis S. Collins,
Director, National Institutes of Health, USA
Gene Myers,
Celera Genomics, USA
Whole Genome Assemblies and Their Validation
Whole Genome Assemblies and Their Validation
Haig H. Kazazian,
Johns Hopkins University School of Medicine, USA
Biology of Human Retrotransposons
Biology of Human Retrotransposons
Evan E. Eichler,
HHMI/University of Washington, USA
Recent Duplication and Dynamic Mutation of the Human Genome
Recent Duplication and Dynamic Mutation of the Human Genome
10:00—11:30
Human Evolution
Meeting has ended...abstracts no longer viewable online.
Svante Pääbo,
Max Planck Institute for Evolutionary Anthropology, Germany
A Comparative Approach to Human Origins
A Comparative Approach to Human Origins
S. Blair Hedges,
Penn State University, USA
A Molecular Timescale for the Evolution of Humans and Other Primates
A Molecular Timescale for the Evolution of Humans and Other Primates
16:30—18:00
Genome-Scale Protein Biology
Meeting has ended...abstracts no longer viewable online.
*
David J. Lockhart,
Amicus Therapeutics, Inc., USA
Rudolf H. Aebersold,
Institute of Molecular Systems Biology, ETH Zürich, Switzerland
Quantitative Proteome Analysis: New Technology and Applications
Quantitative Proteome Analysis: New Technology and Applications
Stephen K. Burley,
Rutgers University, USA
Structural Genomics: An X-ray Crystallographic Approach by the NYSGRC
Structural Genomics: An X-ray Crystallographic Approach by the NYSGRC
20:00—22:00
Poster Sessions 3 & 4: Mendelian Disease Phenotypes/Complex Disease Phenotypes/Computational Biology/Animal Models of Human Disease/Diagnosis, Screening and Pharmacogenomics/Intellectual Property/ELSI
08:00—09:30
Functional and Structural Genomics
Meeting has ended...abstracts no longer viewable online.
Dagmar Ringe,
Brandeis University, USA
Metal Ion Mediated Control of Transcription: The Diphtheria Toxin Repressor
Metal Ion Mediated Control of Transcription: The Diphtheria Toxin Repressor
*
Tony Pawson,
Samuel Lunenfeld Research Institute, Canada
Wiring the Cell Through Modular Protein-Protein Interactions
Wiring the Cell Through Modular Protein-Protein Interactions
09:30—11:30
Mendelian Disease Phenotypes I: Disease Mechanisms. Session Sponsored by Celera Genomics, Inc.
Meeting has ended...abstracts no longer viewable online.
*
Helen H. Hobbs,
University of Texas Southwestern Medical Center, USA
Huda Y. Zoghbi,
HHMI/Baylor College of Medicine, USA
Genetic Studies to Unravel the Pathogenesis of Spinocerebellar Ataxia Type 1
Genetic Studies to Unravel the Pathogenesis of Spinocerebellar Ataxia Type 1
Karen P. Steel,
Wellcome Trust Sanger Institute, UK
Biological Mechanisms Underlying Genetic Deafness
Biological Mechanisms Underlying Genetic Deafness
Jonathan G. Seidman,
Harvard Medical School, USA
Cardiac Hypertrophy in Mice and Men
Cardiac Hypertrophy in Mice and Men
16:00—18:30
Mendelian Disease Phenotypes II: Genomic Disorders and Modifiers
Meeting has ended...abstracts no longer viewable online.
*
Karen P. Steel,
Wellcome Trust Sanger Institute, UK
James R. Lupski,
Baylor College of Medicine, USA
Genomic Disorders: Structural Features of the Genome Can Lead to DNA Rearrangements and Human Disease Traits
Genomic Disorders: Structural Features of the Genome Can Lead to DNA Rearrangements and Human Disease Traits
Lap-Chee Tsui,
University of Hong Kong, China
Molecular Genetics of Cystic Fibrosis and Related Disorders
Molecular Genetics of Cystic Fibrosis and Related Disorders
Arthur M. Buchberg,
Kimmel Cancer Center, USA
Molecular Genetics of Colorectal Cancer Susceptibility
Molecular Genetics of Colorectal Cancer Susceptibility
Batsheva Kerem,
Hebrew University of Jerusalem, Israel
Splicing Effect on Penetrance
Splicing Effect on Penetrance
08:00—10:00
Constructing Animal Models of Human Disease
Meeting has ended...abstracts no longer viewable online.
*
Batsheva Kerem,
Hebrew University of Jerusalem, Israel
Edward M. Rubin,
Lawrence Berkeley National Laboratory, USA
In vivo Libraries
In vivo Libraries
Maja Bucan,
University of Pennsylvania, USA
Dissection of Behavior and Psychiatric Disorders Using the Mouse as a Model: ENU Mutagenesis
Dissection of Behavior and Psychiatric Disorders Using the Mouse as a Model: ENU Mutagenesis
Juan Botas,
Baylor College of Medicine, USA
Drosophila Models of Neurodegenerative Diseases
Drosophila Models of Neurodegenerative Diseases
10:00—12:30
Complex Disease Phenotypes I
Meeting has ended...abstracts no longer viewable online.
*
Eric A. Boerwinkle,
University of Texas, USA
Aravinda Chakravarti,
Johns Hopkins University School of Medicine, USA
Molecular Dissection of Polygenic Disease
Molecular Dissection of Polygenic Disease
T. Conrad Gilliam,
University of Chicago, USA
Molecular Genetics Analysis of Fear and Anxiety
Molecular Genetics Analysis of Fear and Anxiety
Adrian V. S. Hill,
Jenner Institute, University of Oxford, UK
Genetic Susceptibility to Infectious Diseases
Genetic Susceptibility to Infectious Diseases
16:00—18:30
Complex Disease Phenotypes II
Meeting has ended...abstracts no longer viewable online.
*
Edward M. Rubin,
Lawrence Berkeley National Laboratory, USA
Helen H. Hobbs,
University of Texas Southwestern Medical Center, USA
The ABCs of Lipid Metabolism and Atherosclerosis
The ABCs of Lipid Metabolism and Atherosclerosis
Eric A. Boerwinkle,
University of Texas, USA
Genetic Architecture of Human Hypertension
Genetic Architecture of Human Hypertension
Jeffrey M. Drazen,
New England Journal of Medicine, USA
Pharmacogenetics of Asthma
Pharmacogenetics of Asthma
Graeme I. Bell,
University of Chicago, USA
Diabetes
Diabetes
08:00—11:00
Diagnosis, Screening and Pharmacogenomics
Meeting has ended...abstracts no longer viewable online.
*
Alan R. Williamson,
Maywood, UK
Thomas R. Gingeras,
Cold Spring Harbor Laboratory, USA
RNA Transcription and Genome Variation Analysis Using High Density Oligonucleotide Arrays
RNA Transcription and Genome Variation Analysis Using High Density Oligonucleotide Arrays
Bruce Budowle,
FBI Academy, USA
Genomic Tools for Identity Testing and Human Population Genetics
Genomic Tools for Identity Testing and Human Population Genetics
Klaus Lindpaintner,
F. Hoffmann-La Roche AG, Switzerland
Status of Pharmacogenomics and Drug Development
Status of Pharmacogenomics and Drug Development
16:00—18:00
Intellectual Property and ELSI
Meeting has ended...abstracts no longer viewable online.
*
Lap-Chee Tsui,
University of Hong Kong, China
Alan R. Williamson,
Maywood, UK
Gene Patents: Sociably Acceptable Monopolies?
Gene Patents: Sociably Acceptable Monopolies?
Maria C. Freire,
Global Alliance for TB Drug Development, USA
NIH Perspective
NIH Perspective
Hiraku Takebe,
Kinki University, Japan
Bioethical Aspects of Human Genome Analysis -- Comparison Between the East and the West
Bioethical Aspects of Human Genome Analysis -- Comparison Between the East and the West
18:00—19:00
The Future
Meeting has ended...abstracts no longer viewable online.
Aravinda Chakravarti,
Johns Hopkins University School of Medicine, USA
*Session Chair †Invited, not yet responded.
We gratefully acknowledge the generous grant for this conference provided by:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
